S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.10
+360.20
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.24
+1.56
+9.35%
CYRX · CryoPort, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Cryoport Inc (CYRX)
NASDAQ NMS - GLOBAL MARKET
Life Sciences Tools & Services
$18.52
+1.09
(+6.22%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$18.52
$17.42
$18.66
52-WEEK RANGE
$18.52
$7.61
$18.67
What's happening
- CYRX is up 6.22% today, trading at $18.52. — Live quote
- It's trading within 3% of its 52-week high ($18.67). (Finnhub fundamentals)
- Volume today (54,279) is well below its 3-month average of 668,560. (Finnhub fundamentals)
- Reports earnings on 2026-11-11 (after market close), 20 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.20 actual vs. $-0.20 estimated (-1.2%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 6
Buy 7
Hold 2
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (15 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
CYRX
+93.02%
vs S&P 500
+79.65%
1-YEAR RETURN
CYRX
+82.56%
vs S&P 500
+67.40%
6-MONTH RETURN
CYRX
+79.03%
3-MONTH RETURN
CYRX
+12.85%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.20
Est. $-0.20
MISS -1.2%
2026-04-26 (Q1 2026)
$-0.25
Est. $-0.22
MISS -13.2%
2026-01-26 (Q4 2025)
$-0.27
Est. $-0.21
MISS -28.8%
2025-10-26 (Q3 2025)
$-0.18
Est. $-0.22
BEAT +16.4%
Valuation Measures & Ratios
Enterprise Value4$854.7M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)5.02
Price / Book71.61
EV4 / Revenue4.58
EV4 / EBITDA1071.09
Profit Margin-20.05%
Operating Margin-21.25%
Return on Equity (ROE8)-7.47%
Return on Assets (ROA9)-4.89%
Avg Volume (3M)668,560
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $648.6M | $348.8M | $365.5M | $382.3M | $260.2M |
| P/E | 7.80 | 4.39 | 4.03 | 19.40 | -2.41 |
| Price/Sales | 3.48 | 1.95 | 2.16 | 2.32 | 1.66 |
| Price/Book | 1.32 | 0.70 | 0.71 | 0.74 | 0.65 |
| EV/Revenue | 2.03 | 0.43 | 0.65 | 0.84 | 1.43 |
| EV/EBITDA | -30.27 | -8.79 | -10.00 | — | — |
| ROE | 16.94% | 16.04% | 17.68% | 3.80% | -27.10% |
| ROA | 10.99% | 10.40% | 11.72% | 2.55% | -15.44% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short2,362,636
Change from Prior Settlement-15.21%
% of Float—
Days to Cover (Short Ratio)3.38
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 7.7% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +82.6%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is -20.1%. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-08-11; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on CYRX
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $49.0M | $47.8M | $44.2M | $45.5M | $41.0M | $38.3M | $39.7M | $37.3M |
| Gross profit | $22.8M | $21.9M | $21.3M | $21.4M | $18.6M | $17.4M | $17.7M | $15.1M |
| Operating income | -$10.0M | -$9.6M | -$9.9M | -$9.6M | -$7.2M | -$13.4M | -$78.0M | -$17.5M |
| Net income | -$8.3M | -$10.5M | -$6.9M | $108.9M | -$12.0M | $805.0K | -$78.0M | -$18.9M |
| EPS (diluted) | $-0.20 | $-0.25 | $-0.18 | $2.13 | $-0.28 | $-0.02 | $-1.62 | $-0.43 |
| EPS (basic) | $-0.20 | $-0.25 | $-0.18 | $2.13 | $-0.28 | $-0.02 | $-1.62 | $-0.43 |
| Operating margin | -$20 | -$20 | -$22 | -$21 | -$18 | -$35 | -$197 | -$47 |
| Net margin | -$17 | -$22 | -$16 | $240 | -$29 | $2 | -$196 | -$51 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $756.2M | $763.6M | $765.0M | $774.3M | $773.9M | $699.8M | $703.5M | $701.8M |
| Total liabilities | $265.5M | $268.6M | $262.4M | $261.1M | $258.5M | $301.0M | $301.6M | $283.2M |
| Stockholders' equity | $490.7M | $495.0M | $502.6M | $513.3M | $519.1M | $398.8M | $401.9M | $418.6M |
| Total current assets | $460.2M | $470.5M | $476.2M | $484.8M | $489.5M | $411.3M | $341.6M | $350.3M |
| Total current liabilities | $221.0M | $224.9M | $219.0M | $30.7M | $30.1M | $74.0M | $64.6M | $61.4M |
| Cash & equivalents | $269.3M | $272.9M | $250.5M | $255.8M | $243.4M | $36.1M | $34.1M | $31.4M |
| Marketable securities (current) | $127.4M | $130.7M | $160.7M | $165.5M | $182.6M | $207.9M | $216.5M | $228.0M |
| Accounts receivable | $36.5M | $39.0M | $33.4M | $34.9M | $33.4M | $28.4M | $25.3M | $43.5M |
| Inventory | $21.5M | $21.8M | $23.2M | $23.3M | $23.0M | $23.3M | $21.5M | $23.6M |
| Other current assets | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $94.5M | $89.8M | $85.4M | $83.2M | $81.6M | $80.5M | $80.0M | $88.3M |
| Goodwill | $22.1M | $22.1M | $22.4M | $22.4M | $18.7M | $21.0M | $20.6M | $54.1M |
| Intangible assets | $136.0M | $138.7M | $138.1M | $141.3M | $143.6M | $145.4M | $147.9M | $175.8M |
| Other non-current assets | — | — | — | — | — | — | — | — |
| Deferred revenue (current) | $1.7M | $2.3M | $943.0K | $1.4M | $1.7M | $1.8M | $1.1M | $1.1M |
| Other current liabilities | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Other non-current liabilities | $832.0K | $663.0K | $444.0K | $2.7M | $2.6M | $1.4M | $295.0K | $569.0K |
| Common stock & paid-in capital | $51.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $49.0K |
| Retained earnings | -$707.7M | -$699.4M | -$688.9M | -$675.2M | -$668.2M | -$769.2M | -$757.2M | -$738.5M |
| Accumulated other comprehensive income (loss) | -$2.5M | -$3.2M | -$3.5M | -$4.1M | -$5.4M | -$15.7M | -$20.9M | -$16.4M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.1M | $3.7M | $919.0K | $2.2M | -$7.3M | -$4.3M | -$5.5M | $447.0K |
| Investing cash flow | -$5.8M | $18.7M | $56.0K | $14.3M | $230.0M | $5.9M | $3.5M | $153.6M |
| Financing cash flow | $653.0K | $85.0K | -$2.2M | -$2.9M | -$15.9M | -$189.0K | $2.0M | -$155.3M |
| Free cash flow | -$8.0M | -$6.2M | -$4.5M | -$1.3M | -$11.7M | -$7.5M | -$10.7M | -$3.8M |
| Capital expenditures | $9.1M | $10.0M | $5.5M | $3.5M | $4.4M | $3.2M | $5.2M | $4.2M |
| Depreciation & amortization | $6.6M | $6.4M | $6.4M | $6.4M | $7.3M | $7.6M | $7.9M | $7.8M |
| Share-based compensation | $2.4M | $2.4M | $7.0M | $2.5M | $2.0M | $3.1M | $11.9M | $4.1M |
| Deferred income taxes | $267.0K | $236.0K | -$117.0K | -$299.0K | $1.1M | -$26.0K | $6.0K | $639.0K |
| Change in accounts receivable | — | — | — | — | — | — | — | — |
| Change in inventory | -$352.0K | -$1.3M | $97.0K | $421.0K | -$638.0K | $2.3M | -$536.0K | -$284.0K |
| Share repurchases | — | — | $2.0M | $3.7M | $4.3M | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $176.2M | $156.8M | $168.7M | $237.3M | $222.6M |
| Gross profit | $83.1M | $69.7M | $75.3M | $103.9M | $96.6M |
| Operating income | -$36.8M | -$121.7M | -$100.5M | -$31.9M | -$17.8M |
| Net income | $78.3M | -$114.8M | -$99.6M | -$37.3M | -$275.5M |
| EPS (diluted) | $1.40 | $-2.49 | $-2.21 | $-0.93 | $-6.18 |
| EPS (basic) | $1.40 | $-2.49 | $-2.21 | $-0.93 | $-6.18 |
| Operating margin | -$21 | -$78 | -$60 | -$13 | -$8 |
| Net margin | $44 | -$73 | -$59 | -$16 | -$124 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $765.0M | $703.5M | $957.7M | $1.04B | $1.11B |
| Total liabilities | $262.4M | $301.6M | $468.7M | $482.9M | $471.1M |
| Stockholders' equity | $502.6M | $401.9M | $489.0M | $555.8M | $641.8M |
| Total current assets | $476.2M | $341.6M | $535.1M | $604.2M | $693.5M |
| Total current liabilities | $219.0M | $64.6M | $45.6M | $40.9M | $42.6M |
| Cash & equivalents | $250.5M | $34.1M | $35.2M | $29.2M | $139.1M |
| Marketable securities (current) | $160.7M | $216.5M | $410.4M | $486.7M | $489.7M |
| Accounts receivable | $33.4M | $25.3M | $42.1M | $43.9M | $39.4M |
| Inventory | $23.2M | $21.5M | $26.2M | $27.7M | $16.5M |
| Other current assets | — | — | — | — | — |
| Property, plant & equipment | $85.4M | $80.0M | $84.9M | $63.6M | $49.0M |
| Goodwill | $22.4M | $20.6M | $76.4M | $151.1M | $147.0M |
| Intangible assets | $138.1M | $147.9M | $194.4M | $191.0M | $201.4M |
| Other non-current assets | — | — | — | $947.0K | $419.0K |
| Deferred revenue (current) | $943.0K | $1.1M | $1.3M | $439.0K | $547.0K |
| Long-term debt | — | — | — | — | — |
| Other non-current liabilities | $444.0K | $295.0K | $601.0K | $451.0K | $298.0K |
| Common stock & paid-in capital | $50.0K | $50.0K | $49.0K | $48.0K | $50.0K |
| Retained earnings | -$688.9M | -$757.2M | -$642.4M | -$542.8M | -$467.5M |
| Accumulated other comprehensive income (loss) | -$3.5M | -$20.9M | -$26.1M | -$34.5M | — |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$8.6M | -$16.3M | -$757.0K | -$1.9M | $8.1M |
| Investing cash flow | $250.3M | $176.8M | $36.0M | -$59.7M | -$469.3M |
| Financing cash flow | -$21.1M | -$161.5M | -$23.8M | -$39.2M | $564.3M |
| Free cash flow | -$25.0M | -$33.6M | -$39.5M | -$24.0M | -$15.8M |
| Capital expenditures | $16.4M | $17.3M | $38.8M | $22.1M | $23.9M |
| Depreciation & amortization | $27.7M | $30.8M | $27.5M | $22.8M | $20.2M |
| Share-based compensation | $10.1M | $16.6M | $19.8M | $20.1M | $15.3M |
| Deferred income taxes | $661.0K | -$377.0K | -$2.0M | -$411.0K | $231.0K |
| Change in accounts receivable | — | — | — | — | — |
| Change in inventory | $2.2M | -$3.3M | -$1.5M | $14.2M | $6.0M |
| Share repurchases | $10.0M | — | — | $38.0M | $0 |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding CYRX as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-07-18 to 2026-08-11
Recent transactions
- Insiders have net sold 256,441 shares over the last 182 days, across 0 purchases and 5 sales.
- Most recent: SHELTON JERRELL (President, CEO) — Open market sale of 28,800 shares on 2026-08-11.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)256,441 sh(5 txns)
Net Shares-256,441
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| SHELTON JERRELL | President, CEO | Open market sale | 2026-08-11 | 28,800 |
| ZECCHINI EDWARD J | Chief Digital and Tech Officer | Option exercise | 2026-06-11 | 33,600 |
| Mandalam Ramkumar | Director | Open market sale | 2026-06-08 | 23,214 |
| BADDOUR LINDA | Director | Grant / award | 2026-06-05 | 10,350 |
| HANCOCK DANIEL M | Director | Grant / award | 2026-06-05 | 10,350 |
| Hariri Robert J | Director | Grant / award | 2026-06-05 | 10,350 |
| STEFANOVICH ROBERT | Chief Financial Officer | Open market sale | 2026-06-04 | 169,427 |
| Sawicki Mark W | Chief Scientific Officer | Open market sale | 2026-03-23 | 1,341 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-11 | SHELTON JERRELL | President, CEO | Open market sale | 28,800 | $14.91 |
| 2026-06-11 | ZECCHINI EDWARD J | Chief Digital and Tech Officer | Option exercise | 33,600 | $4.80 |
| 2026-06-11 | ZECCHINI EDWARD J | Chief Digital and Tech Officer | Open market sale | 33,600 | $14.47 |
| 2026-06-10 | ZECCHINI EDWARD J | Chief Digital and Tech Officer | Option exercise | 1,400 | $4.80 |
| 2026-06-10 | ZECCHINI EDWARD J | Chief Digital and Tech Officer | Open market sale | 1,400 | $15.23 |
| 2026-06-08 | Mandalam Ramkumar | Director | Open market sale | 23,214 | $15.44 |
| 2026-06-05 | BADDOUR LINDA | Director | Grant / award | 10,350 | $0.00 |
| 2026-06-05 | HANCOCK DANIEL M | Director | Grant / award | 10,350 | $0.00 |
| 2026-06-05 | Hariri Robert J | Director | Grant / award | 10,350 | $0.00 |
| 2026-06-05 | Mandalam Ramkumar | Director | Grant / award | 10,350 | $0.00 |
| 2026-06-04 | STEFANOVICH ROBERT | Chief Financial Officer | Open market sale | 169,427 | $16.27 |
| 2026-04-21 | SHELTON JERRELL | President, CEO | Option exercise | 104,007 | $1.87 |
| 2026-04-06 | SHELTON JERRELL | President, CEO | Option exercise | 50,000 | $1.87 |
| 2026-03-23 | STEFANOVICH ROBERT | Chief Financial Officer | Open market sale | 1,094 | $8.18 |
| 2026-03-23 | SHELTON JERRELL | President, CEO | Open market sale | 2,894 | $8.18 |
| 2026-03-23 | SHELTON JERRELL | President, CEO | Option exercise | 25,000 | $1.87 |
| 2026-03-23 | Sawicki Mark W | Chief Scientific Officer | Open market sale | 1,341 | $8.18 |
| 2026-03-16 | ZECCHINI EDWARD J | See Remarks | Open market sale | 2,014 | $8.00 |
| 2026-03-16 | SHELTON JERRELL | President, CEO | Open market sale | 7,918 | $8.00 |
| 2026-03-16 | Sawicki Mark W | Chief Scientific Officer | Open market sale | 3,235 | $8.00 |
| 2026-03-16 | STEFANOVICH ROBERT | Chief Financial Officer | Open market sale | 2,743 | $8.00 |
| 2026-03-14 | ZECCHINI EDWARD J | See Remarks | Grant / award | 21,322 | $0.00 |
| 2026-03-14 | Sawicki Mark W | Chief Scientific Officer | Grant / award | 22,845 | $0.00 |
| 2026-03-14 | STEFANOVICH ROBERT | Chief Financial Officer | Grant / award | 27,413 | $0.00 |
| 2026-03-12 | STEFANOVICH ROBERT | Chief Financial Officer | Option exercise | 87,188 | $1.87 |
| 2026-03-12 | STEFANOVICH ROBERT | Chief Financial Officer | Open market sale | 38,700 | $7.76 |
| 2025-12-10 | Mandalam Ramkumar | Director | Open market sale | 11,570 | $9.99 |
| 2025-09-11 | Hariri Robert J | Director | Option exercise | 50,000 | $2.66 |
| 2025-09-11 | Hariri Robert J | Director | Open market sale | 25,000 | $9.71 |
| 2025-08-22 | Hariri Robert J | Director | Open market sale | 5,000 | $8.60 |
| 2025-08-19 | STEFANOVICH ROBERT | Chief Financial Officer | Option exercise | 26,164 | $3.07 |
| 2025-08-19 | STEFANOVICH ROBERT | Chief Financial Officer | Open market sale | 9,300 | $8.67 |
| 2025-08-13 | SHELTON JERRELL | President, CEO | Option exercise | 25,000 | $5.00 |
| 2025-07-31 | SHELTON JERRELL | President, CEO | Option exercise | 25,000 | $5.00 |
| 2025-07-24 | SHELTON JERRELL | President, CEO | Option exercise | 25,000 | $5.00 |
| 2025-07-22 | Mandalam Ramkumar | Director | Option exercise | 60,000 | $3.07 |
| 2025-07-22 | Mandalam Ramkumar | Director | Open market sale | 40,728 | $7.24 |
| 2025-07-18 | SHELTON JERRELL | President, CEO | Option exercise | 25,000 | $5.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 06:30 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-11 | 4 | 2026-08-11 | View on SEC.gov → |
| 2026-08-06 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-06-12 | 4 | 2026-06-10 | View on SEC.gov → |
| 2026-06-09 | 8-K | 2026-06-05 | View on SEC.gov → |
| 2026-06-09 | 4 | 2026-06-05 | View on SEC.gov → |
| 2026-06-08 | 4 | 2026-06-04 | View on SEC.gov → |
| 2026-06-08 | 4 | 2026-06-05 | View on SEC.gov → |
| 2026-06-08 | 4 | 2026-06-05 | View on SEC.gov → |
| 2026-06-08 | 4 | 2026-06-05 | View on SEC.gov → |
| 2026-05-05 | 10-Q | 2026-03-31 | View on SEC.gov → |
| 2026-05-04 | 8-K | 2026-05-04 | View on SEC.gov → |
Recent news
Headlines about CYRX (CryoPort, Inc.). Links open the publisher — we don’t host full articles.
-
CryoPort (NASDAQ:CYRX) Reaches New 52-Week High - Time to Buy?
MarketBeat · 2026-10-21 -
BTIG raises target to USD 26 for Cryoport stock
AD HOC NEWS · 2026-10-20 -
CryoPort, Inc. $CYRX Shares Sold by Assenagon Asset Management S.A.
MarketBeat · 2026-10-19 -
Avoiding Lag: Real-Time Signals in (CYRX) Movement
Stock Traders Daily · 2026-10-17 -
Cryoport stock faces estimated November 3 earnings report
AD HOC NEWS · 2026-10-17 -
CryoPort (NASDAQ:CYRX) Share Price Crosses Above Two Hundred Day Moving Average - Should You Sell?
MarketBeat · 2026-10-17 -
CryoPort Q2 2026 Earnings Call Transcript
Benzinga · 2026-10-13 -
BTIG Maintains Buy on CryoPort, Raises Price Target to $26
Benzinga · 2026-10-13
No headlines in this category right now — try “All”.